# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2020 · $471,073

## Abstract

PROJECT SUMMARY: DEVELOPMENTAL FUNDS
Shortly after assuming the Directorship of Sylvester Comprehensive Cancer Center (Sylvester) in 2012,
Stephen D. Nimer, MD, initiated a center-wide effort to ensure that all cancer-relevant investments are
strategically made. Nimer’s first goals were to systematically build needed research infrastructure, connect
individuals and groups of investigators, build teams of scientists to create research programs for the center,
and increase community engagement and outreach activities to gain a greater understanding of the diverse
needs in Sylvester’s catchment area. In 2013, Sylvester leadership initiated a formal strategic planning
process, resulting in the 2014-2018 Strategic Plan. This plan prioritized addressing the needs of Sylvester
members, including the need for better shared resources (SRs), more reliable support for conducting clinical
trials and translational science, and more financial support of outstanding cancer research. Since 2014, a total
of $5.7M has been awarded via the peer-reviewed Intramural Funding Program, which includes nine award
mechanisms to encourage new areas of cancer research, bridge investigator’s grant funding, support junior
faculty, and promote innovative clinical trials that match Sylvester’s strategic goals and promote collaborative
team science. The return on investment, calculated based on results stemming from the direct support of
research projects, has been $25.2M in new grant funding, 22 publications (of which 64% are collaborative),
new research tools, and three applications with one patent approved. To fulfill the needs of the three research
programs, Sylvester has also invested $14M in the development of the Flow Cytometry, Onco-Genomics,
Biostatistics and Bioinformatics, and Behavioral and Community-Based Research Shared Resources. Seventy
percent of Sylvester members utilize services these shared resources provide. Additionally, Sylvester has
invested $2.9M since 2016 in three highly translational developing shared resources: the Biospecimen, Cancer
Modeling, and Molecular Therapeutics Shared Resources, for which CCSG Developmental Funds support is
requested.

## Key facts

- **NIH application ID:** 9975830
- **Project number:** 5P30CA240139-02
- **Recipient organization:** UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- **Principal Investigator:** Stephen D. Nimer
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $471,073
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9975830

## Citation

> US National Institutes of Health, RePORTER application 9975830, Developmental Funds (5P30CA240139-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9975830. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*